| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2862046 | The American Journal of Cardiology | 2006 | 5 Pages |
Abstract
The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association’s (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David E. Cohen, Frank A. Anania, Naga Chalasani,